Companies Integrated Research

Integrated Research

Sydney

Total Offices: 5

967 Total Employees

Year Founded: 1988

View Website

Integrated Research Company Growth, Stability & Outlook

Updated on September 09, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about Integrated Research and has not been reviewed or approved by Integrated Research.

What's the stability & growth outlook for Integrated Research?

Strengths in liquidity, product innovation, and ecosystem partnerships are accompanied by headwinds in revenue momentum, profitability, and renewals. Together, these dynamics suggest a specialist vendor in transition with credible foundations but near-term instability until renewals recover and new products materially offset legacy declines.

Key Insight for Candidates

Defining tradeoff: Niche leadership with entrenched enterprise customers vs. near-term contraction as it pivots to product-led, AI-driven offerings. Expect a turnaround environment with tighter resources, aggressive roadmaps, and renewal headwinds. High impact potential, lower stability.

Evidence in Action

Product-Led Release Cadence — Iris, Prognosis Elevate, and IR Labs anchor a product‑led growth cadence focused on continuous AI feature delivery. Employees get stable investment signals and clearer roadmaps, enabling faster decisions and prioritization around shipping value despite near‑term profitability pressure.
New-Business Scorecard Focus — Pro forma revenue, new‑client licence revenue (+12%), and expansion licence revenue (+110%) are the primary scorecard metrics communicated company‑wide. Employees orient execution toward acquisition and expansion performance, improving focus and forecasting consistency amid renewal softness.

Positive Themes About Integrated Research

Healthy Cash Flow: Cash balances increased and management highlights sufficient runway to invest through the transition. This liquidity supports continued product development and go-to-market execution during a softer revenue period.
Innovation-Driven Growth: Recent launches such as Iris (AI assistant), Prognosis Elevate (as-a-service), and new high-value payments capabilities indicate active product refresh. Early upticks in new-client and expansion licenses suggest these offerings are gaining initial traction.
Strategic Partnerships: Ecosystem ties like ACI Worldwide’s solutions powered by PROGNOSIS and Cisco’s SolutionsPlus listing reinforce market access and credibility in core niches. These partnerships can accelerate adoption in regulated payments and complex UC environments.

Considerations About Integrated Research

Stagnant Revenue: Reported revenue declined year over year and remained down in the latest half, with pro forma measures also showing softness. Management characterizes the current fiscal period as transitional rather than a growth inflection.
Declining Profitability: Profit moved to a loss in the most recent half with EBITDA negative, influenced by credit loss expense and non-recurring prior-year gains. This pressure limits near-term operating leverage until revenue stabilizes.
Weak Customer Retention: A softer renewals book and churn in legacy offerings are weighing on the top line while newer products scale. Near-term outcomes are sensitive to renewal rates across key regions.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.